Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus

Journal of Viral Hepatitis

Volumn 19, Issue 2, 2012, Pages 103-111

  Pham, T N Q ^a   Coffin, C S ^b   Churchill, N D ^a   Urbanski, S J ^b   Lee, S S ^b   Michalak, T I ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

extrahepatic HCV and HBV infections; liver alterations in low level HCV infection; lymphoid cell infection; occult HBV persistence; occult HCV infection

Indexed keywords

ALPHA INTERFERON; PEGINTERFERON ALPHA; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; EXPOSURE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; LIVER BIOPSY; LIVER FIBROSIS; MALE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PLASMA; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRION; VIRUS CARRIER; VIRUS DETECTION; VIRUS GENOME; VIRUS LIKE AGENT;

ANTIVIRAL AGENTS; BIOPSY; BLOOD; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HISTOCYTOCHEMISTRY; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; VIRAL LOAD;

EID: 80053948329     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01442.x     Document Type: Article

References (45)

1. Lavanchy D,. The global burden of hepatitis C. Liver Intl 2009; 29 (Suppl. 1): 74-81.
2. Ganem D, Prince AM,. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129. (Pubitemid 38298992)
3. Fattovich G,. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003; 23: 47-58. (Pubitemid 36254662)
4. Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192: 1880-1889. (Pubitemid 41681885)
5. Blackard JT, Kemmer N, Sherman KE,. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006; 44: 15-22. (Pubitemid 44049134)
6. Chemin I, Vermot-Desroches C, Baginski I, et al. Selective detection of human hepatitis B virus surface and core antigens in peripheral blood mononuclear cell subsets by flow cytometry. J Viral Hepat 1994; 1: 39-44. (Pubitemid 2122917)
7. Pal S, Sullivan DG, Kim S, et al. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 2006; 130: 1107-1116.
8. Pham TNQ, King D, MacParland SA, et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008; 134: 812-822. (Pubitemid 351312726)
9. Roque-Afonso AM, Ducoulombier D, Di Liberto G, et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005; 79: 6349-6357. (Pubitemid 40617238)
10. Zoulim F, Vitvitski L, Bouffard P, et al. Detection of pre-S1 proteins in peripheral blood mononuclear cells from patients with HBV infection. J Hepatol 1991; 12: 150-156.
11. Michalak TI, Pasquinelli C, Guilhot S, et al. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994; 93: 230-239. (Pubitemid 24030841)
12. Cabrerizo M, Bartolome J, Caramelo C, et al. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000; 32: 116-123. (Pubitemid 30432375)
13. Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, et al. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis 2006; 43: 1277-1283. (Pubitemid 44706453)
14. Pham TNQ, MacParland SA, Mulrooney PM, et al. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004; 78: 5867-5874. (Pubitemid 38661674)
15. Radkowski M, Gallegos-Orozco JF, Jablonska J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005; 41: 106-114. (Pubitemid 40066388)
16. Castillo I, Pardo M, Bartolome J, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004; 189: 7-14. (Pubitemid 38122323)
17. Pham TNQ, Coffin CS, Michalak TI,. Occult hepatitis C virus infection: what does it mean? Liver Intl 2010; 30: 502-511.
18. Pham TNQ, Michalak TI,. Factors influencing detection of low levels of hepatitis C virus (HCV) genome and its replication. J Hepatol 2009; 50: S129.
19. Crespo J, Lozano JL, de la CF, et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994; 89: 1147-1151. (Pubitemid 24245785)
20. De Maria N, Colantoni A, Friedlander L, et al. The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 2000; 95: 3529-3536.
21. Fukuda R, Ishimura N, Niigaki M, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999; 58: 201-207. (Pubitemid 29278020)
22. Liaw YF, Chen YC, Sheen IS,. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004; 126: 1024-1029.
23. Raimondo G, Brunetto MR, Pontisso P, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 2006; 43: 100-107. (Pubitemid 43733596)
24. Sagnelli E, Coppola N, Marrocco C, et al. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course. J Clin Virol 2006; 35: 317-320. (Pubitemid 43188980)
25. Coffin CS, Mulrooney-Cousins PM, Lee SS, et al. Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus. Liver Intl 2007; 27: 722-726. (Pubitemid 47097325)
26. Gruener NH, Jung MC, Ulsenheimer A, et al. Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response. J Hepatol 2002; 37: 866-869. (Pubitemid 35404229)
27. Chen SY, Kao CF, Chen CM, et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003; 278: 591-607.
28. Guo H, Zhou T, Jiang D, et al. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J Virol 2007; 81: 10072-10080. (Pubitemid 350067711)
29. Schuttler CG, Fiedler N, Schmidt K, et al. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 2002; 37: 855-862. (Pubitemid 35404227)
30. Coppola N, Pisapia R, Tonziello G, et al. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection. Antivir Ther 2008; 13: 307-318. (Pubitemid 351535382)
31. Rodriguez-Inigo E, Bartolome J, Ortiz-Movilla N, et al. Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection. J Virol 2005; 79: 15578-15581. (Pubitemid 43032340)
32. Bellecave P, Gouttenoire J, Gajer M, et al. Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference. Hepatology 2009; 50: 46-55.
33. Eyre NS, Phillips RJ, Bowden S, et al. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells. J Hepatol 2009; 51: 446-457.
34. Michalak TI, Pardoe IU, Coffin CS, et al. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999; 29: 928-938. (Pubitemid 29109612)
35. MacParland SA, Pham TNQ, Gujar SA, et al. De novo infection and propagation of wild-type hepatitis C virus in human T lymphocytes in vitro. J Gen Virol 2006; 87: 3577-3586. (Pubitemid 44816991)
36. MacParland SA, Pham TNQ, Guy CS, et al. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 2009; 49: 1431-1441.
37. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293. (Pubitemid 26260021)
38. Bartolome J, Lopez-Alcorocho JM, Castillo I, et al. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 2007; 81: 7710-7715. (Pubitemid 47047856)
39. Pham TNQ, MacParland SA, Coffin CS, et al. Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 2005; 86: 657-666. (Pubitemid 40331246)
40. Pham TNQ, Mulrooney-Cousins PM, Mercer SE, et al. Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection. J Viral Hepat 2007; 14: 537-548. (Pubitemid 47075430)
41. Sagnelli E, Coppola N, Pisaturo M, et al. HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV. Hepatology 2009; 49: 1090-1097.
42. Bernardin F, Tobler L, Walsh I, et al. Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia. Hepatology 2008; 47: 1146-1152.
43. George SL, Bacon BR, Brunt EM, et al. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 2009; 49: 729-738.
44. Maylin S, Martinot-Peignoux M, Moucari R, et al. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology 2008; 135: 821-829.
45. Hoare M, Gelson WT, Rushbrook SM, et al. Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection. Hepatology 2008; 48: 1737-1745.